Physician

Psychiatry

Extein works in the field of Psychiatry. He attended Yale University School of Medicine. Yale University School of Medicine is a top medical college. Yale University School of Medicine has a rank of 7 in research and a 57 in primary care He over the years received 4 awards: "Gulfstream FL-Palm Beach", "Top Doctors: Florida", "Top MD" and "Super Doctor". Irl L. Extein is a published MD. He has 89 publications published. The most current publication "14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa." He is registered with Medicare and accepts Medicare payments.

Publications

---

• High doses of levothyroxine for refractory rapid cycling.
• Hypothesized neurochemical models for psychiatric syndromes in Alcohol and drug dependence.
• Diet aids, mania, and affective illness.
• Grades of thyroid failure in 100 depressed and anergic psychiatric inpatients.
• Failure of naloxone to reduce manic symptoms.
• Supression of plasma cortisol in depressed patients by acute intravenous methadone infusion.
• Deficient prolactin response to morphine in depressed patients.
• Clonidine in acute opiate withdrawal.
• Rapid Mood cycling and concomitant cortisol changes produced by cyproheptadine.
• Opiate detoxification with lofexidine.
• Clonidine in opiate withdrawal.
• The 24-hour LH test in the diagnosis and assessment of response to treatment of patients with anorexia nervosa.
• Hypothyroidism and depression. Evidence from complete thyroid function evaluation.
• Diagnosis of depression in the 1980s.
• Plasma haloperidol levels and clinical response in acute schizophrenia.
• The dexamethasone suppression test in depressed adolescents.
• The future of private psychiatric hospitals.
• Case reports of L-triiodothyronine potentiation.
• Clonidine: inpatient studies from 1978 to 1981.
• Methadone and morphine in depression [proceedings].
• Antimanic, antidepressant, and antipanic effects of opiates: clinical, neuroanatomical, and biochemical evidence.
• Serum prolactin and opiate withdrawal.
• The dexamethasone suppression and thyrotropin-releasing hormone tests and response to treatment in unipolar depression.
• Lofexidine blocks acute opiate withdrawal.
• "Symptomless" autoimmune thyroiditis in depression.
• Neuroendocrine abnormalities in affective Disorders.
• Thyroid-stimulating hormone response to thyrotropin-releasing hormone in unipolar depression before and after clinical improvement.
• Does subclinical hypothyroidism predispose to tricyclic-induced rapid Mood cycles?
• Clinical correlates of the TRH infusion test in primary depression.
• Using the protirelin test to distinguish mania from schizophrenia.
• The TRH test in the diagnosis of Major and minor depression.
• The thyrotropin-releasing hormone test in the diagnosis of unipolar depression.
• Neuroendocrine diagnostic test in psychiatry.
• Thyrotropin-releasing hormone test and male unipolar depression.
• Relationship of thyrotropin-releasing hormone test and dexamethasone suppression test abnormalities in unipolar depression.
• Clinical utility of clonidine in opiate withdrawal.
• Dopamine and serum prolactin in methadone withdrawal.
• Differentiating mania from schizophrenia by the TRH test.
• The thyroid-stimulating hormone response to thyrotropin-releasing hormone in mania and Bipolar depression.
• TRH test in depression.
• Cortisol secretion and urinary MHPG in unipolar depression.
• Models for care and research: closed-staff private hospitals.
• Identifying depression secondary to lithium-induced hypothyroidism.
• Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
• Specific norepinephrine and serotonin uptake inhibitors in man: a crossover study with pharmacokinetic, biochemical, neuroendocrine and behavioral parameters.
• The TRH test in affective Disorders: experience in a private clinical setting.
• The dexamethasone suppression and thyrotropin-releasing hormone tests in depressed Borderline patients.
• Specificity of the DST and the TRH test for major depression in Alcoholics.
• Nortriptyline plasma levels and clinical response in patients with familial pure unipolar depression and blunted TRH tests.
• The thyrotropin-releasing hormone and dexamethasone suppression tests in the familial classification of depression.
• The specificity of the thyrotropin-releasing hormone (TRH) test and dexamethasone suppression test (DST) for major depressive illness in Alcoholics.
• Thyroid failure and protirelin (thyrotropin-releasing hormone) test abnormalities in depressed outpatients.
• Plasma cortisol and beta-endorphin immunoreactivity in nonMajor and Major depression.
• A possible opioid receptor dysfunction in some depressive Disorders.
• Methadone-induced endorphin dysfunction in addicts.
• Neuroanatomical sites of action of clonidine in opiate withdrawal: the locus coeruleus connection.
• Evidence for an endorphin dysfunction in methadone addicts: lack of ACTH response to naloxone.
• Behavioral and biological effects of acute beta-endorphin injection in schizophrenic and depressed patients.
• The TRH test and urinary MHPG in unipolar depression.
• [The hypothalamo-hypophyseo-thyroid axis in psychiatric Disorders. Review].
• Psychopharmacologic treatment of depression.
• Therapeutic window for plasma haloperidol in acute schizophrenic psychosis.
• Use of ECT with treatment-resistant depressed patients at the National Institute of Mental Health.
• Psychopharmacology in psychiatric emergencies.
• Clonidine and opiate withdrawal.
• Anti-endorphin effects of methadone.
• Dexamethasone suppression tests in depression and response to treatment.
• Accumulation of 3-methoxy-4-hydroxyphenylglycol-sulfate in rabbit cerebrospinal fluid following probenecid.
• Accumulation of 3H-homovanillic acid in rabbit brain and cerebrospinal fluid following intravenous 3H-L-dopa.
• Number of cortisol time-points and dexamethasone suppression test sensitivity for Major depression.
• Cocaine update: from bench to bedside.
• The adolescent Cocaine epidemic.
• Posthospital outcome in suburban Drug addicts.
• Hepatitis in 101 consecutive suburban Cocaine and opiate users.
• Thyroid hormone potentiation of tricyclics.
• Psychiatric applications of thyroid tests.
• Bromocriptine treatment of Cocaine withdrawal symptoms.
• Recent fluoxetine treatment and complications of tricyclic therapy.
• 14C-homovanillic acid in the cerebrospinal fluid of parkinsonian patients after intravenous 14C-L-dopa.
• Methylphenidate-induced choreoathetosis.
• Rapid Mood cycles after a noradrenergic but not a serotonergic antidepressant.
• State and trait in psychiatric practice.
• Comparative pharmacokinetics of zimelidine and desipramine in man following acute and chronic administration.
• The pharmacologic meaning of successful antipsychotic-antidepressant combinations.
• Dopamine-mediated behavior produced by the enkephalin analogue FK 33-824.
• Changes in lymphocyte beta-adrenergic receptors in depression and mania.
• Decrease in serum prolactin by naloxone: evidence against antidopamine and antipsychotic effects.
• Increase in serum prolactin by exogenous and endogenous opiates: evidence for antidopamine and antipsychotic effects.

Schools

---

• Yale Univ Sch Of Med

• Yale University School Of Med

• Nimh

Procedures Preformed

---

• Electroconvulsive Therapy (ECT)
• Group Psychotherapy
• Psychiatric Medication Therapy
• Psychotherapy and Psychophysiological Therapy (incl. Biofeedback)

Conditions Treated

---

• Adjustment Disorder
• Alcohol-Induced Mental Disorders
• Alcoholism (Alcohol Dependence)
• Anxiety
• View All

Doctors Specialties

---

• Psychiatry

Accepted Insurances

---

Awards

---

• Gulfstream FL-Palm Beach
• Top Doctors: Florida
• Top MD
• Super Doctor

Education

---

• Yale-New Haven Hospital
• Yale University School of Medicine

Drug Facts

---

NPI NUMBER		1801962675
NPPES Provider LastName		EXTEIN
NPPES Provider FirstName		IRL
NPPES Provider ZIPCode		334846534
NPPES Provider State		FL
Specialty Description		Psychiatry
Total Claim Count		10821.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1801962675
Last Name Of The Provider	EXTEIN
First Name Of The Provider	IRL
View All

Similar Doctors

---

	Dr. Lacresha Hall, MD
	Dr. Gretchen M. Garcia, MD This Doctor is OpenDoctor Recommended.
	Dr. Louis Hafken, MD This Doctor is OpenDoctor Recommended.
	Dr. Levi Cohen, MD
	Dr. Charles A. Raele, MD This Doctor is OpenDoctor Recommended.
	Dr. Praturi Y. Sharma, MD This Doctor is OpenDoctor Recommended.
	Dr. Marc D. Weiss, MD
	Dr. Heidi Erickson, MD This Doctor is OpenDoctor Recommended.
	Dr. Efrain Mendez, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog